A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

Summary

The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use Disorder (AUD). Participation in this study will last approximately 56 weeks.

Timeline

Start

2025-10-15

Primary completion

2028-04

Completion

2028-04

Drugs

Indications